U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry UNKNOWN
Molecular Formula C24H33N3O2S
Molecular Weight 427.603
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DIXYRAZINE

SMILES

CC(CN1CCN(CCOCCO)CC1)CN2C3=C(SC4=C2C=CC=C4)C=CC=C3

InChI

InChIKey=MSYUMPGNGDNTIQ-UHFFFAOYSA-N
InChI=1S/C24H33N3O2S/c1-20(18-26-12-10-25(11-13-26)14-16-29-17-15-28)19-27-21-6-2-4-8-23(21)30-24-9-5-3-7-22(24)27/h2-9,20,28H,10-19H2,1H3

HIDE SMILES / InChI
Molecular Formula C24H33N3O2S
Molecular Weight 427.603
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description

Dixyrazine is a typical antipsychotic of the phenothiazine group. Under a trademark Esucos, the drug was used in European countries as an antipsychotic, antiemetic and sedative with oral doses ranging from 20 to 75 mg daily. Dixyrazine has also been given by injection.

CNS Activity

CNS Active
3,913

Approval Year

Unknown
139,594

PubMed

Sample Use Guides

In Vivo Use Guide
The oral dose of dixyrazine ranges from 20 to 75 mg daily. Dixyrazine has also been given by intramuscular injection at 0.5 mg/kg
Route of Administration: Other
Substance Class Chemical
Record UNII
7H368W3AYC
Record Status Validated (UNII)
Record Version
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966